Abnormal fronto-striatal functional connectivity in Parkinson's disease

Area of Science:

• Neuroscience
• Neurology
• Brain Imaging

Background:

• Parkinson's disease (PD) involves dopamine depletion, affecting striatal function and cortico-striatal-thalamic-cortical circuits.
• Cognitive deficits in PD are often associated with fronto-striatal circuit dysfunction.
• Previous studies used seed-based methods, limiting the quantification of network-wide interactions.

Purpose of the Study:

• To investigate fronto-striatal network functional connectivity in Parkinson's disease using functional connectivity degree.
• To quantify interactions between brain regions within the fronto-striatal network in PD patients.
• To explore the relationship between functional connectivity alterations and clinical factors like disease duration.

Main Methods:

• Utilized functional connectivity degree to assess the fronto-striatal network in Parkinson's disease patients and healthy controls.
• Compared total functional connectivity degree between PD patients and controls for key regions like the putamen and globus pallidum.
• Analyzed correlations between fronto-pallial functional connectivity degree and disease duration in PD patients.

Main Results:

• Parkinson's disease patients exhibited significantly decreased total functional connectivity degree in the left putamen and right globus pallidum within fronto-striatal networks compared to controls.
• Negative correlations were found between fronto-pallial functional connectivity degree (right globus pallidum with specific frontal gyri) and disease duration in PD patients.
• These findings highlight specific alterations in fronto-striatal network connectivity in Parkinson's disease.

Conclusions:

• Fronto-striatal functional connectivity is demonstrably abnormal in Parkinson's disease patients.
• The observed connectivity deficits may underlie both motor and cognitive impairments characteristic of PD.
• Functional connectivity degree offers a valuable metric for understanding network-level brain dysfunction in neurodegenerative diseases like Parkinson's.